179 related articles for article (PubMed ID: 25572464)
1. VEGF-A inhibition ameliorates podocyte apoptosis via repression of activating protein 1 in diabetes.
Bai X; Geng J; Li X; Yang F; Tian J
Am J Nephrol; 2014; 40(6):523-34. PubMed ID: 25572464
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetes.
Bai X; Li X; Tian J; Zhou Z
PLoS One; 2014; 9(4):e96117. PubMed ID: 24759991
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of AP-1 transcription activator induces myc-dependent apoptosis in HL60 cells.
Park S; Hahm ER; Lee DK; Yang CH
J Cell Biochem; 2004 Apr; 91(5):973-86. PubMed ID: 15034932
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil and valsartan inhibit podocyte apoptosis in streptozotocin-induced diabetic rats.
Lv W; Zhang Y; Guan G; Li P; Wang J; Qi D
Pharmacology; 2013; 92(3-4):227-34. PubMed ID: 24158161
[TBL] [Abstract][Full Text] [Related]
6. Enhanced glycogen synthase kinase-3β activity mediates podocyte apoptosis under diabetic conditions.
Paeng J; Chang JH; Lee SH; Nam BY; Kang HY; Kim S; Oh HJ; Park JT; Han SH; Yoo TH; Kang SW
Apoptosis; 2014 Dec; 19(12):1678-90. PubMed ID: 25284613
[TBL] [Abstract][Full Text] [Related]
7. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
Wang S; Li Y; Huang YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
[TBL] [Abstract][Full Text] [Related]
8. Tempol reduces podocyte apoptosis via PARP signaling pathway in experimental diabetes mellitus.
Peixoto EB; Papadimitriou A; Lopes de Faria JM; Lopes de Faria JB
Nephron Exp Nephrol; 2012; 120(2):e81-90. PubMed ID: 22555049
[TBL] [Abstract][Full Text] [Related]
9. Podocyte hypertrophy precedes apoptosis under experimental diabetic conditions.
Lee SH; Moon SJ; Paeng J; Kang HY; Nam BY; Kim S; Kim CH; Lee MJ; Oh HJ; Park JT; Han SH; Yoo TH; Kang SW
Apoptosis; 2015 Aug; 20(8):1056-71. PubMed ID: 25953318
[TBL] [Abstract][Full Text] [Related]
10. The balance of autocrine VEGF-A and VEGF-C determines podocyte survival.
Müller-Deile J; Worthmann K; Saleem M; Tossidou I; Haller H; Schiffer M
Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1656-67. PubMed ID: 19828679
[TBL] [Abstract][Full Text] [Related]
11. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
[TBL] [Abstract][Full Text] [Related]
12. High glucose induces vascular endothelial growth factor production in human synovial fibroblasts through reactive oxygen species generation.
Tsai CH; Chiang YC; Chen HT; Huang PH; Hsu HC; Tang CH
Biochim Biophys Acta; 2013 Mar; 1830(3):2649-58. PubMed ID: 23274526
[TBL] [Abstract][Full Text] [Related]
13. Xuezhikang () reduced renal cell apoptosis in streptozocin-induced diabetic rats through regulation of Bcl-2 family.
Lu WN; Zheng FP; Lai DW; Li H
Chin J Integr Med; 2016 Aug; 22(8):611-8. PubMed ID: 25847779
[TBL] [Abstract][Full Text] [Related]
14. Valsartan ameliorates podocyte loss in diabetic mice through the Notch pathway.
Gao F; Yao M; Cao Y; Liu S; Liu Q; Duan H
Int J Mol Med; 2016 May; 37(5):1328-36. PubMed ID: 26985716
[TBL] [Abstract][Full Text] [Related]
15. Extract of the aerial parts of Aster koraiensis reduced development of diabetic nephropathy via anti-apoptosis of podocytes in streptozotocin-induced diabetic rats.
Sohn E; Kim J; Kim CS; Kim YS; Jang DS; Kim JS
Biochem Biophys Res Commun; 2010 Jan; 391(1):733-8. PubMed ID: 19944074
[TBL] [Abstract][Full Text] [Related]
16. The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis.
Wada T; Pippin JW; Terada Y; Shankland SJ
Kidney Int; 2005 Oct; 68(4):1618-29. PubMed ID: 16164639
[TBL] [Abstract][Full Text] [Related]
17. Emodin ameliorates high glucose induced-podocyte epithelial-mesenchymal transition in-vitro and in-vivo.
Chen T; Zheng LY; Xiao W; Gui D; Wang X; Wang N
Cell Physiol Biochem; 2015; 35(4):1425-36. PubMed ID: 25791065
[TBL] [Abstract][Full Text] [Related]
18. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
19. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
[TBL] [Abstract][Full Text] [Related]
20. FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells.
Jung DS; Li JJ; Kwak SJ; Lee SH; Park J; Song YS; Yoo TH; Han SH; Lee JE; Kim DK; Moon SJ; Kim YS; Han DS; Kang SW
Am J Physiol Renal Physiol; 2008 Aug; 295(2):F595-604. PubMed ID: 18524857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
